Lead Autoimmune Program

About NuAcRes

NuAcRes is a private, pre-clinical stage biotech developing antibody therapeutics for oncology and autoimmune indications. The company leverages a proprietary technology platform to engineer antibodies with enhanced specificity and functionality. While still in the research and development phase, NuAcRes is positioning itself in the competitive but high-value antibody therapeutics market, with a pipeline of early-stage assets. Its success will depend on successful translation of its platform science into clinical candidates and securing further partnership or investment funding.

Therapeutic Areas

Other Autoimmune Disease (unspecified) Drugs